Takeaway

The presenter views the simultaneous entry of CME and Euronext into the European dairy derivatives market as a significant validation of its importance. He argues that the resulting competition and investment in market education will be a net benefit for the space, with market participants ultimately deciding if both contracts thrive or if one becomes the preferred venue.

What the presenter said

• Two major exchanges, Euronext and CME, are now competing in the same European dairy derivatives market. [00:00]
• The presenter sees this competition as a "real validation" of the European dairy market. [00:11]
• He believes that having both exchanges invest in education and market development will be beneficial for the market as a whole. [00:38]
• The market itself will ultimately decide whether the parallel CME and Euronext contracts can both run successfully or if one becomes the preferred destination for liquidity. [00:43]
• Both exchanges have significant strengths to contribute to the development of the European market. [00:55]

Trade ideas

None stated. The presenter did not put forward an actionable trade idea, focusing instead on the structural development of the European dairy derivatives market.